Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.2. Segment Definitions
1.2.1. Product
1.2.2. Flow Type
1.2.3. Stage
1.2.4. Indication
1.2.5. End Use
1.2.6. Sales Channel
1.3. Estimates and Forecast Timeline
1.4. Research Methodology
1.5. Information Procurement
1.5.1. Purchased Database
1.5.2. Internal Database
1.5.3. Secondary Sources
1.5.4. Primary Research
1.6. Information Analysis
1.6.1. Data Analysis Models
1.7. Market Formulation & Data Visualization
1.8. Model Details
1.8.1. Commodity Flow Analysis
1.9. List of Secondary Sources
1.10. Objectives
Chapter 2. Executive Summary
2.1. Market Snapshot
2.2. Segment Snapshot
2.3. Competitive Landscape Snapshot
Chapter 3. Market Variables, Trends, & Scope
3.1. Market Lineage Outlook
3.2. Technology Overview
3.3. Pricing Analysis
3.4. Consumer Behavior Analysis
3.4.1. Adoption Pattern
3.4.2. Purchasing behaviors
3.5. Market Dynamics
3.5.1. Market Driver Analysis
3.5.1.1. Rising geriatric population
3.5.1.2. Growing prevalence of chronic diseases
3.5.1.3. Shifting trend toward consumption of disease-specific formulas
3.5.1.4. Growing demand for neonatal and preterm enteral feeding
3.5.2. Market Restraint Analysis
3.5.2.1. Lack of awareness in the medical community
3.5.2.2. Improper categorization of clinical nutrition
3.5.3. Market Opportunity Analysis
3.5.4. Industry Challenges
3.5.4.1. Complications associated with small-bore connectors
3.5.4.2. Risks associated with enteral feeding
3.6. Business Environment Analysis
3.6.1. Porter’s Five Forces Analysis
3.6.1.1. Supplier power
3.6.1.2. Buyer power
3.6.1.3. Substitution threat
3.6.1.4. Threat of new entrant
3.6.1.5. Competitive rivalry
3.6.2. PESTLE Analysis
3.6.2.1. Political landscape
3.6.2.2. Economic landscape
3.6.2.3. Social landscape
3.6.2.4. Technological landscape
3.6.2.5. Environmental landscape
3.6.2.6. Legal landscape
3.6.3. Impact of COVID-19
Chapter 4. U.S. Enteral Feeding Formulas Market: Product Estimates & Trend Analysis
4.1. Segment Dashboard
4.2. Enteral Feeding Formulas Market: Product Movement Analysis, 2023 & 2030 (USD Million)
4.2.1. Standard formula
4.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
4.2.2. Disease-specific formula
4.2.2.1. Market Estimates and forecasts, 2018 - 2030(USD Million)
Chapter 5. U.S. Enteral Feeding Formulas Market: Flow Type Estimates & Trend Analysis
5.1. Segment Dashboard
5.2. Enteral Feeding Formulas Market: Flow Type Movement Analysis, 2023 & 2030 (USD Million)
5.2.1. Intermittent Feeding Flow
5.2.1.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
5.2.2. Continuous Feeding Flow
5.2.2.1. Market Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 6. U.S. Enteral Feeding Formulas Market: Stage Estimates & Trend Analysis
6.1. Segment Dashboard
6.2. Enteral Feeding Formulas Market: Stage Movement Analysis, 2023 & 2030 (USD Million)
6.3. Adult
6.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
6.4. Pediatric
6.4.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 7. U.S. Enteral Feeding Formulas Market: Indication Estimates & Trend Analysis
7.1. Segment Dashboard
7.2. Enteral Feeding Formulas Market: Indication Movement Analysis, 2023 & 2030 (USD Million)
7.3. Alzheimer’s Disease
7.3.1. Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4. Nutrition Deficiency
7.4.1. Nutrition Deficiency, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.2. Cancer Care
7.4.3. Cancer Care, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.4. Diabetes
7.4.5. Diabetes, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.6. Chronic Kidney Diseases
7.4.7. Chronic Kidney Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.8. Orphan Diseases
7.4.9. Orphan Diseases, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.10. Dysphagia
7.4.11. Dysphagia, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.12. Pain Management
7.4.13. Pain Management, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.14. Malabsorption/GI Disorder/Diarrhea
7.4.15. Malabsorption/Gi Disorder/Diarrhea, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
7.4.16. Others
7.4.17. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 8. U.S. Enteral Feeding Formulas Market: End Use Estimates & Trend Analysis
8.1. Segment Dashboard
8.2. Enteral Feeding Formulas Market: End Use Movement Analysis, 2023 & 2030 (USD Million)
8.2.1. Hospitals
8.2.1.1. Hospitals Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.1.1.1.Cardiology
8.2.1.1.1.1. Cardiology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.1.1.2.Neurology
8.2.1.1.2.1. Neurology, Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.1.1.3.Critical Care (ICU)
8.2.1.1.3.1. Critical Care (ICU) Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.1.1.4.Oncology
8.2.1.1.4.1. Oncology Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.1.1.5.Others
8.2.1.1.5.1. Others Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
8.2.2. Home Care
8.2.2.1. Home Care Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
Chapter 9. U.S. Enteral Feeding Formulas Market: Sales Channel Estimates & Trend Analysis
9.1. Segment Dashboard
9.2. Enteral Feeding Formulas Market: Sales Channel Movement Analysis, 2023 & 2030 (USD Million)
9.2.1. Online Sales
9.2.1.1. Online Sales Market Revenue Estimates and forecasts, 2018 - 2030 (USD Million)
9.2.2. Retail Sales
9.2.2.1. Retail Sales Market Revenue Estimates and forecasts, 2018 - 2030
9.2.3. Institutional Sales
9.2.3.1. Institutional Sales Market Revenue Estimates and forecasts, 2018 - 2030
Chapter 10. Competitive Landscape
10.1. Company Market Share Analysis, 2024 (%)
10.2. Company Categorization
10.3. Company Profiles/Listing
10.3.1. Ajinomoto Cambrooke
10.3.1.1. Overview
10.3.1.2. Financial performance
10.3.1.3. Product benchmarking
10.3.1.4. Strategic initiatives
10.3.2. Global Health Products, Inc.
10.3.2.1. Overview
10.3.2.2. Financial performance
10.3.2.3. Product benchmarking
10.3.2.4. Strategic initiatives
10.3.3. Kate Farms
10.3.3.1. Overview
10.3.3.2. Financial performance
10.3.3.3. Product benchmarking
10.3.3.4. Strategic initiatives
10.3.4. Abbott
10.3.4.1. Overview
10.3.4.2. Financial performance
10.3.4.3. Product benchmarking
10.3.4.4. Strategic initiatives
10.3.5. Danone S.A
10.3.5.1. Overview
10.3.5.2. Financial performance
10.3.5.3. Product benchmarking
10.3.5.4. Strategic initiatives
10.3.6. Kabi AG
10.3.6.1. Overview
10.3.6.2. Financial performance
10.3.6.3. Product benchmarking
10.3.6.4. Strategic initiatives
10.3.7. Nestlé
10.3.7.1. Overview
10.3.7.2. Financial performance
10.3.7.3. Product benchmarking
10.3.7.4. Strategic initiatives
10.3.8. Primus Pharmaceuticals, Inc.
10.3.8.1. Overview
10.3.8.2. Financial performance
10.3.8.3. Product benchmarking
10.3.8.4. Strategic initiatives
10.3.9. Mead Johnson & Company, LLC
10.3.9.1. Overview
10.3.9.2. Financial performance
10.3.9.3. Product benchmarking
10.3.9.4. Strategic initiatives
10.3.10. Alcresta Therapeutics
10.3.10.1. Overview
10.3.10.2. Financial performance
10.3.10.3. Product benchmarking
10.3.10.4. Strategic initiatives
10.3.11. Real Food Blends
10.3.11.1. Overview
10.3.11.2. Financial performance
10.3.11.3. Product benchmarking
10.3.11.4. Strategic initiatives
10.3.12. B. Braun SE
10.3.12.1. Overview
10.3.12.2. Financial performance
10.3.12.3. Product benchmarking
10.3.12.4. Strategic initiatives
List of Tables
Table 1. List of secondary sources
Table 2. List of abbreviations
Table 3. U.S. Enteral feeding formulas market, Product, 2018 - 2030 (USD Million)
Table 4. U.S. Enteral feeding formulas market, by Flow Type, 2018 - 2030 (USD Million)
Table 5. U.S. Enteral feeding formulas market, by Stage, 2018 - 2030 (USD Million)
Table 6. U.S. Enteral feeding formulas market, by Indication, 2018 - 2030 (USD Million)
Table 7. U.S. Enteral feeding formulas market, by End Use, 2018 - 2030 (USD Million)
Table 8. U.S. Enteral feeding formulas market, by Sales Channel, 2018 - 2030 (USD Million)
List of Figures
Fig. 1 Market research process
Fig. 2 Information procurement
Fig. 3 Primary research pattern
Fig. 4 Market research approaches
Fig. 5 Value chain-based sizing & forecasting
Fig. 6 Market formulation & validation
Fig. 7 Market segmentation
Fig. 8 Market snapshot
Fig. 9 Segment snapshot
Fig. 10 Competitive landscape snapshot
Fig. 11 Market trends & outlook
Fig. 12 Market driver relevance analysis (current & future impact)
Fig. 13 Market restraint relevance analysis (current & future impact)
Fig. 14 PESTLE analysis
Fig. 15 Porter’s five forces analysis
Fig. 16 U.S. Enteral feeding formulas market: Products movement analysis
Fig. 17 U.S. Enteral feeding formulas market: Products outlook and key takeaways
Fig. 18 Standard Formula market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 19 Disease-Specific Formulas market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 20 U.S. Enteral feeding formulas market: Flow Type movement analysis
Fig. 21 U.S. Enteral feeding formulas market: Flow Type outlook and key takeaways
Fig. 22 Intermittent feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 23 Continuous feeding flow market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 24 U.S. Enteral feeding formulas market: Stage movement analysis
Fig. 25 U.S. Enteral feeding formulas market: Stage outlook and key takeaways
Fig. 26 Adults market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 27 Pediatrics market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 28 U.S. Enteral feeding formulas market: Indication movement analysis
Fig. 29 U.S. Enteral feeding formulas market: Indication outlook and key takeaways
Fig. 30 Alzheimer’s market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 31 Nutrition Deficiency market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 32 Cancer Care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 33 Diabetes market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 34 Chronic Kidney Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 35 Orphan Diseases market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 36 Dysphagia market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 37 Pain Management market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 38 Malabsorption/GI Disorder/Diarrhea market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 39 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 40 U.S. Enteral feeding formulas market: End Use movement analysis
Fig. 41 U.S. Enteral feeding formulas market: End Use outlook and key takeaways
Fig. 42 Cardiology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 43 Neurology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 44 Critical Care (ICU) market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 45 Oncology market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 46 Others market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 47 Home Care market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 48 U.S. Enteral feeding formulas market: Sales Channel movement analysis
Fig. 49 U.S. Enteral feeding formulas market: Sales Channel outlook and key takeaways
Fig. 50 Online sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 51 Retail sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 52 Institutional sales market estimates and forecast, 2018 - 2030 (USD Million)
Fig. 53 Market Participant Categorization
Fig. 54 Strategy mapping
Fig. 55 Company market position analysis
